SEATTLE -- Parse Biosciences, the leader in scalable and accessible single cell sequencing, welcomed Tempus as the newest member of its Certified Service Provider (CSP) Program. Together, the companies will broaden access to high-quality and scalable single cell and empower Tempus to advance its integrated multi-omics offerings.

Launched in 2024, Parse’s CSP Program brings together a global community of premier service providers, giving scientists straightforward access to advanced single cell technologies. By joining this network, Tempus combines Parse’s proven scalability and quality with its own multi-omics expertise, offering customers a reliable path from exploratory research to large, data-driven studies.

“We share Parse’s mission to offer reliable and emerging solutions for research, and we look forward to offering our customers single cell sequencing to further this work,” said Mike Yasiejko, Executive Vice President at Tempus.

“We’ve always been focused on making single cell analysis accessible, scalable, and impactful, and this work with Tempus advances that goal,” said Alex Rosenberg, PhD, Co-founder and CEO of Parse Biosciences. “By joining forces, we can deliver the scale and integrated data needed to tackle complex biological questions across the life sciences.”